Pfizer partners to develop gene therapy to treat ALS – CNBC
CNBC |
Pfizer partners to develop gene therapy to treat ALS
CNBC Sangamo Therapeutics and Pfizer said on Wednesday they would work together to develop a gene therapy to treat ALS, a disease that affects nerve cells in the brain and the spinal cord. The gene therapy will also be used to treat patients with a brain … Sangamo, Pfizer Partner on Gene Therapy for ALS, FTLD Sangamo, Pfizer Collaborate On Zinc Finger Protein Gene Therapy For ALS Sangamo teams up with Pfizer to develop gene therapy to treat ALS; shares ahead 4% premarket |
